Home › NDC Lookup › RxCUI directory › RxCUI 2119706

Latanoprost 0.05 MG/ML / netarsudil 0.2 MG/ML Ophthalmic Solution [Rocklatan] — RxCUI 2119706

Name: Latanoprost 0.05 MG/ML / netarsudil 0.2 MG/ML Ophthalmic Solution [Rocklatan] (RxCUI 2119706)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic branded drug

RxCUI 2119706 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2119706

Official nameLatanoprost 0.05 MG/ML / netarsudil 0.2 MG/ML Ophthalmic Solution [Rocklatan]

Concept typeSemantic branded drug (SBD)

RxNorm statusCurrent RxNorm concept

Also known asrocklatan (netarsudil 0.02 % / latanoprost 0.005 % ) Ophthalmic Solution; rocklatan 0.02 % / 0.005 % Ophthalmic Solution

FDA products mapped1

Package NDCs mapped2

Reported Medicaid activity (SDUD)26,083 prescriptions · 44 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Netarsudil Ophthalmic: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Rhopressa lowers high pressure inside your eye. It is used for open-angle glaucoma and ocular hypertension. Keeping eye pressure down is the goal of treatment.
Put one drop in the affected eye or eyes once a day in the evening. Don't use it twice a day, since that isn't well tolerated. If you miss a dose, just use the next evening dose.
Quite possibly. Redness was the most common side effect, in about half of patients, and about 6% stopped because of it. Other common effects include eye pain when the drop goes in,...
Take your contact lenses out before using the drops. You can put them back in 15 minutes later.

📖 Read our full Netarsudil Ophthalmic guide →

🕸️ Concept Web — How Latanoprost 0.05 MG/ML / netarsudil 0.2 MG/ML Op... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Latanoprost 0.05 MG/ML / netarsudil 0.2 MG/ML Ophthalmic Solution [Rocklatan] RxCUI 2119706 Semantic branded drug · SBD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 3

The active substance itself — no strength, form, or brand attached yet.
- Latanoprost 43611 IN
- Netarsudil 1992864 IN
- Latanoprost / netarsudil 2119700 MIN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Rocklatan 2119702 BN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Latanoprost / netarsudil Ophthalmic Solution 2119699 SCDF
- Latanoprost / netarsudil Ophthalmic Product 2119698 SCDG
- Latanoprost / netarsudil Ophthalmic Solution [Rocklatan] 2119704 SBDF
- Rocklatan Ophthalmic Product 2119705 SBDG
- Ophthalmic Solution 7670 DF
- Ophthalmic Product 1151135 DFG
Clinical & branded drugs 4

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Latanoprost 0.05 MG/ML / netarsudil 0.2 MG/ML Ophthalmic Solution 2119701 SCD
- Latanoprost 0.05 MG/ML 323956 SCDC
- Netarsudil 0.2 MG/ML 2102445 SCDC
- Latanoprost 0.05 MG/ML / netarsudil 0.2 MG/ML [Rocklatan] 2119703 SBDC

Showing up to 8 concepts per family — 14 of 14 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Latanoprost 0.05 MG/ML / netarsudil 0.2 MG/ML Ophthalmic Solution SCD · 2119701
Latanoprost 0.05 MG/ML SCDC · 323956
Netarsudil 0.2 MG/ML SCDC · 2102445
Latanoprost / netarsudil Ophthalmic Solution SCDF · 2119699
Latanoprost / netarsudil Ophthalmic Product SCDG · 2119698

Brand-Name Concepts

Latanoprost 0.05 MG/ML / netarsudil 0.2 MG/ML [Rocklatan] SBDC · 2119703
Latanoprost / netarsudil Ophthalmic Solution [Rocklatan] SBDF · 2119704
Rocklatan Ophthalmic Product SBDG · 2119705
Rocklatan BN · 2119702

📦 FDA Products & Package NDCs

1 product · 2 package NDCs

2 package NDCs map to RxCUI 2119706 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
70727-0529-25	1 BOTTLE, PLASTIC in 1 CARTON (70727-529-25) / 2.5 mL in 1...	Rocklatan	Alcon Laboratories, Inc.	2019-03-12
70727-0529-99	1 BOTTLE, PLASTIC in 1 CARTON (70727-529-99) / 2.5 mL in 1...	Rocklatan	Alcon Laboratories, Inc.	2019-03-12

Observed labelers: Alcon Laboratories, Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.

Per ml · median

$139.5060

Range $139.5060–$139.5060 · middle 50% $139.5060–$139.5060 · 1 NDCs

Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.